Assembly Biosciences, Inc.
ASMB
$26.93
$0.281.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.20% | 28.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.20% | 28.03% | |||
| Cost of Revenue | 8.58% | 4.00% | |||
| Gross Profit | -19.64% | 21.54% | |||
| SG&A Expenses | 1.89% | -2.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.02% | 2.49% | |||
| Operating Income | -11.59% | 13.80% | |||
| Income Before Tax | -15.65% | 15.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -15.65% | 14.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.65% | 14.68% | |||
| EBIT | -11.59% | 13.80% | |||
| EBITDA | -11.64% | 13.84% | |||
| EPS Basic | -13.40% | 25.72% | |||
| Normalized Basic EPS | -13.39% | 26.26% | |||
| EPS Diluted | -13.40% | 25.72% | |||
| Normalized Diluted EPS | -13.39% | 26.26% | |||
| Average Basic Shares Outstanding | 1.99% | 14.86% | |||
| Average Diluted Shares Outstanding | 1.99% | 14.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||